share_log

CERo Therapeutics Announced The Publication In Clinical Cancer Research A Paper Titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia."

CERo Therapeutics Announced The Publication In Clinical Cancer Research A Paper Titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia."

CerO Therapeutics 宣佈在《臨床癌症研究》雜誌上發表一篇題爲 “利用工程化 T 細胞靶向 TIM-4-L 治療急性髓系白血病” 的論文。
Benzinga ·  03/07 20:20

CERo Therapeutics Announced The Publication In Clinical Cancer Research A Paper Titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia."

CerO Therapeutics 宣佈在《臨床癌症研究》雜誌上發表一篇題爲 “利用工程化 T 細胞靶向 TIM-4-L 治療急性髓系白血病” 的論文。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論